|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
115,717,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,565,825 |
Avg
Vol: |
723,021 |
52
Week Range: |
$2.39 - $2.39 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Beaver Carolyn |
CFO |
|
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,214 |
30,823 |
|
- |
|
Lindsay Ronald M |
Director |
|
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,363 |
206,467 |
|
- |
|
Welch William J |
CEO |
|
2015-02-10 |
4 |
D |
$3.47 |
$17,607 |
D/D |
(5,074) |
42,627 |
|
- |
|
Welch William J |
CEO |
|
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,500 |
47,701 |
|
- |
|
Van Den Boom Dirk |
CSSO |
|
2015-02-10 |
4 |
D |
$3.47 |
$16,281 |
D/D |
(4,692) |
58,220 |
|
- |
|
Van Den Boom Dirk |
CSSO |
|
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
62,912 |
|
- |
|
Weiner Robin |
Sr VP Reg Affairs & Quality |
|
2015-02-10 |
4 |
D |
$3.47 |
$15,278 |
D/D |
(4,403) |
25,126 |
|
- |
|
Weiner Robin |
Sr VP Reg Affairs & Quality |
|
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,000 |
29,529 |
|
- |
|
Hixson Harry F Jr |
Director |
|
2015-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,938 |
233,794 |
|
- |
|
Lai Goldman Myla |
Director |
|
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,294 |
48,494 |
|
- |
|
Pendarvis David |
Director |
|
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,054 |
77,778 |
|
- |
|
Slacik Charles P |
Director |
|
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,033 |
20,033 |
|
- |
|
Buechler Kenneth F |
Director |
|
2015-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
19,398 |
74,290 |
|
- |
|
Welch William J |
CEO |
|
2014-12-10 |
4 |
D |
$3.73 |
$15,334 |
D/D |
(4,111) |
32,763 |
|
- |
|
Welch William J |
CEO |
|
2014-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,938 |
36,874 |
|
- |
|
Van Den Boom Dirk |
CSSO |
|
2014-12-10 |
4 |
D |
$3.73 |
$13,145 |
D/D |
(3,524) |
50,412 |
|
- |
|
Van Den Boom Dirk |
CSSO |
|
2014-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
53,936 |
|
- |
|
Monko Alexander Michael |
Sr. VP, Genetic Analysis |
|
2014-05-30 |
4 |
D |
$3.07 |
$54,379 |
D/D |
(17,713) |
67,508 |
|
- |
|
Monko Alexander Michael |
Sr. VP, Genetic Analysis |
|
2014-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,500 |
74,837 |
|
- |
|
94 Records found
|
|
Page 4 of 4 |
|
|